Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients-Reference-Cited by-同舟云学术

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients

Published:2015-11-20 Issue:11 Volume:10 Page:e0143348
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bae Myoung Nam,Kim Su Hyun,Kim Young Ok,Jin Dong Chan,Song Ho Chul,Choi Euy Jin,Kim Yong-Lim,Kim Yon-Su,Kang Shin-Wook,Kim Nam-Ho,Yang Chul Woo,Kim Yong Kyun

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis;PS Parfrey;Clin J Am Soc Nephrol,2009

2. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients;H Frank;Kidney Int,2004

3. Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin;N Goldberg;Am Heart J,1992

4. Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin;IC Macdougall;Lancet,1990

5. Relationship between erythropoietin resistance index and left ventricular mass and function and cardiovascular events in patients on chronic hemodialysis;S Chung;Hemodial Int,2012

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Budget impact analysis on the Italian healthcare system of roxadustat for the treatment of anemia due to chronic kidney disease;Global and Regional Health Technology Assessment;2024-09-10

2. Early erythroferrone levels can predict the long‐term haemoglobin responses to erythropoiesis‐stimulating agents;British Journal of Pharmacology;2024-04-23

3. Influencing factors of clinical efficacy of roxadustat among hemodialysis patients;Renal Failure;2024-02-12

4. The Influence of Precursor Depletion and dose Regimens on Resistance to Erythropoiesis-Stimulating Agents: Insights from Simulations with Instantaneous Dose-Adaptation Algorithm;Journal of Pharmaceutical Sciences;2024-01

5. Prevalence and risk factors of erythropoiesis stimulating agents hyporesponsiveness in chronic hemodialysis patients attending nephrology center of Benghazi;Libyan Journal of Medical Research;2024-01-01